J Neurol Surg B Skull Base 2024; 85(03): 247-254
DOI: 10.1055/a-2036-0652
Original Article

Headache in Patients with Sellar Disease: Clinicomorphological Predictors of Headache and the Outcome of Endoscopic Transsphenoidal Surgery

1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
2   Department of Neurosurgery, John Hunter Hospital, Newcastle, NSW, Australia
,
Raquel Alvarado
1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
,
Benjamin P. Jonker
3   Department of Neurosurgery, St Vincent's Hospital, Sydney, Australia
4   Institute of Academic Surgery and Department of Neurosurgery, Royal Prince Alfred Hospital, Sydney, Australia
5   Brain and Mind Centre, University of Sydney, Australia
,
Mark J. Winder
3   Department of Neurosurgery, St Vincent's Hospital, Sydney, Australia
6   St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, Australia
,
Peter Earls
1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
7   Department of Anatomical Pathology, St Vincent's Hospital, Sydney, Australia
,
Raewyn Campbell
1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
8   Department of Otolaryngology Head and Neck Surgery, Royal Prince Alfred Hospital, Sydney, Australia
9   Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia
,
Larry H. Kalish
1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
10   Department of Otolaryngology, Head and Neck Surgery, Concord General Hospital, University of Sydney, Sydney, Australia
11   Faculty of Medicine, University of Sydney, Sydney, Australia
,
Raymond Sacks
1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
9   Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia
10   Department of Otolaryngology, Head and Neck Surgery, Concord General Hospital, University of Sydney, Sydney, Australia
,
Andrew S. Davidson
9   Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia
,
Ann McCormack
6   St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, Australia
12   Department of Endocrinology, St Vincent's Hospital, Sydney, Australia
13   Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, Australia
,
Richard J. Harvey
1   Rhinology and Skull Base Research Group, Applied Medical Research Centre, University of New South Wales, Sydney, Australia
9   Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, Australia
› Institutsangaben

Abstract

Objectives Sellar pathologies are frequently found on imaging performed to investigate headache. However, both headache and incidental sellar lesions are common. Hence, this study prospectively examined headache prevalence, phenotype, and severity in patients with sellar pathologies and the impact of transsphenoidal surgery on headache.

Methods Patients undergoing transsphenoidal resection of sellar lesions were consecutively recruited. At baseline, participants were defined as having headache or not and headache phenotype was characterized using validated questionnaires. Headache severity was assessed at baseline and 6 months postoperatively using the Headache Impact Test-6 (HIT-6) and Migraine Disability Assessment Score (MIDAS). Tumor characteristics were defined using radiological, histological, and endocrine factors. Primary outcomes included baseline headache prevalence and severity and headache severity change at 6 months postoperatively. Correlation between headache and radiological, histological, and endocrine characteristics was also of interest.

Results Sixty participants (62% female, 47.1 ± 18.6 years) were recruited. Sixty-three percent possessed baseline headache. HIT-6 scores were higher in patients with primary headache risk factors, including younger age (R2  = −0.417, p = 0.010), smoking history (63.31 ± 7.93 vs 54.44 ± 9.21, p = 0.0060), and family headache history (68.13 ± 7.01 vs 54.94 ± 9.11, p = 0.0030). Headaches were more common in patients with dural invasion (55.70 ± 12.14 vs 47.18 ± 10.15, p = 0.027) and sphenoid sinus invasion (58.87 ± 8.97 vs 51.29 ± 10.97, p = 0.007). Postoperative severity scores improved more with higher baseline headache severity (HIT-6: R2 = −0.682, p < 0.001, MIDAS: R2 = −0.880, p < 0.0010) and dural invasion (MIDAS: −53.00 ± 18.68 vs 12.00 ± 17.54, p = 0.0030).

Conclusion Headaches in sellar disease are likely primary disorders triggered or exacerbated by sellar pathology. These may respond to surgery, particularly in patients with severe headache and dural invasion.



Publikationsverlauf

Eingereicht: 17. Juli 2022

Angenommen: 09. Februar 2023

Accepted Manuscript online:
15. Februar 2023

Artikel online veröffentlicht:
20. März 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Levy MJ, Jäger HR, Powell M, Matharu MS, Meeran K, Goadsby PJ. Pituitary volume and headache: size is not everything. Arch Neurol 2004; 61 (05) 721-725
  • 2 Stovner Lj, Hagen K, Jensen R. et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27 (03) 193-210
  • 3 Feldkamp J, Santen R, Harms E, Aulich A, Mödder U, Scherbaum WA. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol (Oxf) 1999; 51 (01) 109-113
  • 4 Ezzat S, Asa SL, Couldwell WT. et al. The prevalence of pituitary adenomas: a systematic review. Cancer 2004; 101 (03) 613-619
  • 5 Vernooij MW, Ikram MA, Tanghe HL. et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007; 357 (18) 1821-1828
  • 6 Arnold M. Headache Classification Committee of the International Headache Society (IHS) the International Classification of Headache Disorders. Cephalalgia 2018; 38 (01) 1-211
  • 7 Levy MJ, Matharu MS, Meeran K, Powell M, Goadsby PJ. The clinical characteristics of headache in patients with pituitary tumours. Brain 2005; 128 (Pt 8): 1921-1930
  • 8 Schankin CJ, Reifferscheid AK, Krumbholz M. et al. Headache in patients with pituitary adenoma: clinical and paraclinical findings. Cephalalgia 2012; 32 (16) 1198-1207
  • 9 Siegel S, Weber Carneiro R, Buchfelder M. et al. Presence of headache and headache types in patients with tumors of the sellar region-can surgery solve the problem? Results of a prospective single center study. Endocrine 2017; 56 (02) 325-335
  • 10 Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology 1993; 43 (09) 1678-1683
  • 11 Suwanwela N, Phanthumchinda K, Kaoropthum S. Headache in brain tumor: a cross-sectional study. Headache 1994; 34 (07) 435-438
  • 12 Gondim JA, de Almeida JPC, de Albuquerque LAF, Schops M, Gomes E, Ferraz T. Headache associated with pituitary tumors. J Headache Pain 2009; 10 (01) 15-20
  • 13 Khan RB, Merchant TE, Boop FA. et al. Headaches in children with craniopharyngioma. J Child Neurol 2013; 28 (12) 1622-1625
  • 14 Abe T, Matsumoto K, Kuwazawa J, Toyoda I, Sasaki K. Headache associated with pituitary adenomas. Headache 1998; 38 (10) 782-786
  • 15 Gravdahl GB, Tronvik EA, Fougner SL, Solheim O. Pituitary adenoma and non-acute headache: is there an association, and does treatment help?. World Neurosurg 2016; 92: 284-291
  • 16 Hayashi Y, Kita D, Iwato M. et al. Significant improvement of intractable headache after transsphenoidal surgery in patients with pituitary adenomas; preoperative neuroradiological evaluation and intraoperative intrasellar pressure measurement. Pituitary 2016; 19 (02) 175-182
  • 17 Jahangiri A, Wagner JR, Chin AT. et al. Incidence of headache as a presenting complaint in over 1000 patients with sellar lesions and factors predicting postoperative improvement. Clin Neurol Neurosurg 2015; 132: 16-20
  • 18 Wang S-J, Hung C-W, Fuh J-L, Lirng J-F, Hwu C-M. Cranial autonomic symptoms in patients with pituitary adenoma presenting with headaches. Acta Neurol Taiwan 2009; 18 (02) 104-112
  • 19 Wolf A, Goncalves S, Salehi F. et al. Quantitative evaluation of headache severity before and after endoscopic transsphenoidal surgery for pituitary adenoma. J Neurosurg 2016; 124 (06) 1627-1633
  • 20 Dimopoulou C, Athanasoulia AP, Hanisch E. et al. Clinical characteristics of pain in patients with pituitary adenomas. Eur J Endocrinol 2014; 171 (05) 581-591
  • 21 Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 2000; 85 (05) 1789-1793
  • 22 Gondim JA, Tella Jr OI, Schops M. Intrasellar pressure and tumor volume in pituitary tumor: relation study. Arq Neuropsiquiatr 2006; 64 (04) 971-975
  • 23 Meij BP, Lopes M-BS, Ellegala DB, Alden TD, Laws Jr ER. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 2002; 96 (02) 195-208
  • 24 Knosp E, Steiner E, Kitz K, Matula C. Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 1993; 33 (04) 610-617 , discussion 617–618
  • 25 Andrée C, Vaillant M, Barre J. et al. Development and validation of the EUROLIGHT questionnaire to evaluate the burden of primary headache disorders in Europe. Cephalalgia 2010; 30 (09) 1082-1100
  • 26 Steiner TJ, Gururaj G, Andrée C. et al. Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire. J Headache Pain 2014; 15 (01) 3
  • 27 Yang M, Rendas-Baum R, Varon SF, Kosinski M. Validation of the Headache Impact Test (HIT-6™) across episodic and chronic migraine. Cephalalgia 2011; 31 (03) 357-367
  • 28 Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology 2001; 56 (6, Suppl 1): S20-S28
  • 29 Cote DJ, Besasie BD, Hulou MM, Yan SC, Smith TR, Laws ER. Transsphenoidal surgery for Rathke's cleft cyst can reduce headache severity and frequency. Pituitary 2016; 19 (01) 57-64
  • 30 Isono M, Kamida T, Kobayashi H, Shimomura T, Matsuyama J. Clinical features of symptomatic Rathke's cleft cyst. Clin Neurol Neurosurg 2001; 103 (02) 96-100
  • 31 Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol 2012; 15 (Suppl. 01) S15-S22
  • 32 Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008; 7 (04) 354-361
  • 33 Taylor FR. Tobacco, nicotine, and headache. Headache 2015; 55 (07) 1028-1044
  • 34 Kosaras B, Jakubowski M, Kainz V, Burstein R. Sensory innervation of the calvarial bones of the mouse. J Comp Neurol 2009; 515 (03) 331-348
  • 35 Stammberger H, Wolf G. Headaches and sinus disease: the endoscopic approach. Ann Otol Rhinol Laryngol Suppl 1988; 134 (5, suppl): 3-23
  • 36 Pereira-Neto A, Borba AM, Mello PA, Naves LA, Araújo Jr AS, Casulari LA. Mean intrasellar pressure, visual field, headache intensity and quality of life of patients with pituitary adenoma. Arq Neuropsiquiatr 2010; 68 (03) 350-354
  • 37 Bossolo P, Canepari C, Daguati MM, Cozzi A, Fioravanti M, Ferrari E. Chronobiological aspects of headache syndromes due to sellar or pituitary pathology. Cephalalgia 1983; 3 (1, Suppl 1): 117-121
  • 38 Benveniste RJ, King WA, Walsh J, Lee JS, Naidich TP, Post KD. Surgery for Rathke cleft cysts: technical considerations and outcomes. J Neurosurg 2004; 101 (04) 577-584
  • 39 Fan M-C, Wang QL, Wang JF. et al. Surgical treatment of symptomatic Rathke's cleft cysts: clinical features, therapy considerations and outcomes. Chin Med J (Engl) 2012; 125 (16) 2919-2924
  • 40 Fleseriu M, Yedinak C, Campbell C, Delashaw JB. Significant headache improvement after transsphenoidal surgery in patients with small sellar lesions. J Neurosurg 2009; 110 (02) 354-358
  • 41 Kim E. Symptomatic Rathke cleft cyst: clinical features and surgical outcomes. World Neurosurg 2012; 78 (05) 527-534
  • 42 Potts MB, Jahangiri A, Lamborn KR, Blevins LS, Kunwar S, Aghi MK. Suprasellar Rathke cleft cysts: clinical presentation and treatment outcomes. Neurosurgery 2011; 69 (05) 1058-1068 , discussion 1068–7
  • 43 Rizzoli P, Iuliano S, Weizenbaum E, Laws E. Headache in patients with pituitary lesions: a longitudinal cohort study. Neurosurgery 2016; 78 (03) 316-323